Micropenis

Micropenis, medically defined as a stretched penile length of 3.67 inches (9.3 cm) or less in adults, is a rare condition affecting approximately 0.6% of males globally. The diagnosis requires normal internal and external male genitalia except for the reduced size, with the condition identified when penile length falls at least 2.5 standard deviations below the age-appropriate mean.

The primary cause involves insufficient testosterone production during fetal development or after birth, often stemming from hormonal imbalances in the hypothalamic-pituitary-gonadal axis or genetic disorders. In newborns, a penis less than 0.75 inches (1.9 cm) indicates micropenis, compared to the average 1.4 inches.

While micropenis typically doesn't threaten physical health, it can cause significant psychological anxiety, particularly during adolescence and adulthood. Treatment options include testosterone therapy, usually initiated in childhood through injections or topical creams, which may promote growth to normal ranges in some boys. In adulthood, hormonal treatment often yields limited results, making surgical reconstruction an alternative consideration.

Importantly, men with micropenis can maintain satisfying sexual lives through intimacy techniques focusing on other pleasure sources like oral sex. Psychological support from therapists is often recommended alongside medical evaluation by urologists or endocrinologists.